Among these, pTau217 has emerged as the most reliable and robust marker for Aβ-positivity, offering superior diagnostic accuracy and prognostic utility in the early detection of AD, showing comparable accuracy to CSF biomarkers and an optimal correlation with Aβ (8, 11), and tau PET tracers (8). The gene discussed is MAPT; the disease is Alzheimer disease.